Molecular docking studies confirmed stable binding interactions (binding energies: –4.9 to –6.8 kcal/mol) of BITC and CA with key cancer-related proteins (ERK2, p38 MAPK, Bcl-2, Keap1-Nrf2, GST). The gene discussed is BCL2; the disease is cancer.